echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Multiple sclerosis drugs improve memory in Alzheimer's disease model mice

    Multiple sclerosis drugs improve memory in Alzheimer's disease model mice

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    M.


    Through the mouse model, the researchers found that when Glatiramer acetate was used, the microglia (part of the brain's immune system) changed and cognitive behavior improved


    “In general, these findings provide further evidence that therapies that modify the immune system can effectively treat Alzheimer’s disease.


    Glatiramer acetate (Glatiramer acetate) is a synthetic peptide compound, developed and manufactured by the Israeli pharmaceutical company TEVA, under the trade name Copaxone®, which was approved by the US FDA for the treatment of multiple sclerosis in 1996.


    Dawling A.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.